Perhaps patient 8 will be part of C/5 seeing C/4 is safe and seemingly not producing much viral response
They've met all criteria and approval of FDA commitee which they have to be part of being new innovation
Cant see why not.
Why delay any further
- Forums
- ASX - By Stock
- Ann: Chairman's Address to Shareholders
Perhaps patient 8 will be part of C/5 seeing C/4 is safe and...
-
- There are more pages in this discussion • 22 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
SKS
SKS Technologies wins US$90M award to supply power to international hyperscale data centre in Melbourne
RNU
Renascor wins a funding boost given it wants to produce a critical mineral – but $5M award pales in comparison to some